Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 289 to 290 of 290 entries
Sorted by: Best Match Show Resources per page
Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity.

Respiratory medicine

Kraen M, Frantz S, Nihlén U, Engström G, Löfdahl CG, Wollmer P, Dencker M.
PMID: 33895626
Respir Med. 2021 Jun;182:106404. doi: 10.1016/j.rmed.2021.106404. Epub 2021 Apr 17.

Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that in recent years has been reported to have significant effects on numerous tissues. Chronic obstructive pulmonary disease (COPD) is associated with hypophosphatemia but the evidence for elevated plasma levels...

Cite
Kraen M, Frantz S, Nihlén U, et al. Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity. Respir Med. 2021;182:106404doi: 10.1016/j.rmed.2021.106404.
Kraen, M., Frantz, S., Nihlén, U., Engström, G., Löfdahl, C. G., Wollmer, P., & Dencker, M. (2021). Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity. Respiratory medicine, 182106404. https://doi.org/10.1016/j.rmed.2021.106404
Kraen, M, et al. "Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity." Respiratory medicine vol. 182 (2021): 106404. doi: https://doi.org/10.1016/j.rmed.2021.106404
Kraen M, Frantz S, Nihlén U, Engström G, Löfdahl CG, Wollmer P, Dencker M. Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity. Respir Med. 2021 Jun;182:106404. doi: 10.1016/j.rmed.2021.106404. Epub 2021 Apr 17. PMID: 33895626.
Copy Download .nbib Format: NLM
Helping Families Thrive: Co-Designing a Program to Support Parents of Children with Medical Complexity.

Healthcare quarterly (Toronto, Ont.)

Krantz C, Hynes M, DesLauriers A, Kitcher LL, MacMillan T, Paradis D, Curry S.
PMID: 34297663
Healthc Q. 2021 Jul;24(2):40-46. doi: 10.12927/hcq.2021.26547.

Families of children with medical complexity (CMC) face significant challenges beyond those related to caring for their child's medical condition. Parents of CMC report a variety of concerns impacting their social, emotional and financial well-being. This paper details how...

Cite
Krantz C, Hynes M, DesLauriers A, et al. Helping Families Thrive: Co-Designing a Program to Support Parents of Children with Medical Complexity. Healthc Q. 2021;24(2):40-46doi: 10.12927/hcq.2021.26547.
Krantz, C., Hynes, M., DesLauriers, A., Kitcher, L. L., MacMillan, T., Paradis, D., & Curry, S. (2021). Helping Families Thrive: Co-Designing a Program to Support Parents of Children with Medical Complexity. Healthcare quarterly (Toronto, Ont.), 24(2), 40-46. https://doi.org/10.12927/hcq.2021.26547
Krantz, Chantal, et al. "Helping Families Thrive: Co-Designing a Program to Support Parents of Children with Medical Complexity." Healthcare quarterly (Toronto, Ont.) vol. 24,2 (2021): 40-46. doi: https://doi.org/10.12927/hcq.2021.26547
Krantz C, Hynes M, DesLauriers A, Kitcher LL, MacMillan T, Paradis D, Curry S. Helping Families Thrive: Co-Designing a Program to Support Parents of Children with Medical Complexity. Healthc Q. 2021 Jul;24(2):40-46. doi: 10.12927/hcq.2021.26547. PMID: 34297663.
Copy Download .nbib Format: NLM
Showing 289 to 290 of 290 entries